Cimetidine and the gastric mucosal barrier.
Open Access
- 1 August 1977
- Vol. 18 (8) , 631-635
- https://doi.org/10.1136/gut.18.8.631
Abstract
The histamine H2-receptor antagonist, cimetidine, when given topically or parenterally, did not affect net luminal Na+ gain or net luminal H+ loss in vagally-denervated pouches of antrectomised dogs. Cimetidine did not affect disruption of the mucosal barrier by 5 mmol/l or 20 mmol/l sodium taurocholate.This publication has 23 references indexed in Scilit:
- CIMETIDINE IN DUODENAL ULCER Controlled TrialThe Lancet, 1976
- Proceedings: A controlled trial of H2-receptor antagonists in prophylaxis of bleeding from gastrointestinal erosions in fulminant hepatic failure.1976
- TREATMENT OF STRESS-INDUCED UPPER GASTROINTESTINAL HÆMORRHAGE WITH METIAMIDEThe Lancet, 1976
- Pharmacological evaluation of cimetidine, a new histamine H2‐receptor antagonist, in healthy man.British Journal of Clinical Pharmacology, 1975
- Effect of gastric secretory inhibitors on the gastric mucosal barrier.Gut, 1975
- INHIBITION OF NOCTURNAL ACID SECRETION IN DUODENAL ULCER BY ONE ORAL DOSE OF METIAMIDEThe Lancet, 1974
- Etiology of gastric ulcer.1972
- Definition and Antagonism of Histamine H2-receptorsNature, 1972
- Source of the Histamine Released During Damage to the Gastric Mucosa by Acetic AcidGastroenterology, 1968
- Ethanol Damage to Canine Oxyntic Glandular Mucosa.Experimental Biology and Medicine, 1967